Literature DB >> 3158374

Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.

N Fujita, M Nakahiro, I Fukuchi, K Saito, H Yoshida.   

Abstract

It is well established that a pertussis toxin, islet activating protein (IAP), interacts directly with the Ni regulatory protein involved in the receptor-adenylate cyclase system. In this study we investigated the effect of the toxin on the dopaminergic function of the central nervous system in conjunction with the adenylate cyclase system. Direct bilateral microinjection of the toxin into rat striatum reduced the stereotyped behavior induced by apomorphine. This inhibitory effect was observed even 40 h after administration of the toxin, whereas the inhibition by haloperidol disappeared within 15 h. Toxin administration did not influence either the Bmax or affinity of specific binding of [3H]spiroperidol to the striatal membrane. However, it increased the IC50 value of apomorphine for the specific binding of [3H]spiroperidol. GTP (10(-4) M) had little effect on the apparent affinity of apomorphine to the [3H]spiroperidol binding sites in IAP-treated membrane, though an effect was clearly observed in untreated membrane. [3H]Spiroperidol binding sites were increased 34 +/- 8% (n = 4) on chronic treatment of haloperidol for 2 weeks. On the contrary, on long-term administration of IAP the ligand binding sites were decreased by 25 +/- 10% (n = 4). These results indicate that pertussis toxin can interact with the Ni protein coupled with striatal D2-dopamine receptor. Inhibition of the coupling between Ni protein and the D2-dopamine receptor attenuated the manifestation of rat stereotyped behavior. Furthermore, chronic administration of dopamine antagonist resulted in the up-regulation of the D2-dopamine receptor, while long-term inhibition of coupling between the D2-dopamine receptor and Ni regulatory protein reduced the amount of receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158374     DOI: 10.1016/0006-8993(85)91576-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

2.  Neurochemical and behavioural evidence that dopamine D-2 receptors in striatum couple to the Ni regulatory protein and inhibition of cyclic AMP accumulation.

Authors:  E Kelly; A L Willcocks; S R Nahorski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

3.  Presynaptic opioid receptors on dopaminergic nerves in the rabbit caudate nucleus: coupling to pertussis toxin-sensitive G-proteins and interaction with D2 autoreceptors?

Authors:  R Jackisch; H Hotz; C Allgaier; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-03       Impact factor: 3.000

4.  Effects of pertussis toxin on the behavioural and ECoG spectrum changes induced by clonidine and yohimbine after their microinfusion into the locus coeruleus.

Authors:  G B De Sarro; G Bagetta; C Ascioti; V Libri; G Nisticò
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

5.  Association of two pertussis toxin-sensitive G-proteins with the D2-dopamine receptor from bovine striatum.

Authors:  Z Elazar; G Siegel; S Fuchs
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

6.  Why is there motor deterioration in Parkinson's disease during systemic infections-a hypothetical view.

Authors:  Florian Brugger; Roberto Erro; Bettina Balint; Georg Kägi; Paolo Barone; Kailash P Bhatia
Journal:  NPJ Parkinsons Dis       Date:  2015-08-27

Review 7.  Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emission tomography imaging.

Authors:  Vladimir Shalgunov; Aren van Waarde; Jan Booij; Martin C Michel; Rudi A J O Dierckx; Philip H Elsinga
Journal:  Med Res Rev       Date:  2018-11-18       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.